CEO Representation. Subject to the last sentence of Section 3.1(f), if the term of the Chief Executive Officer as a director on the Board is to expire in conjunction with any annual or special meeting of stockholders at which directors are to be elected, the Chief Executive Officer shall be included in the slate of nominees recommended by the Board for election.
Appears in 4 contracts
Sources: Stockholders Agreement (McAfee Corp.), Stockholders Agreement (McAfee Corp.), Stockholders Agreement (Surgical Care Affiliates, Inc.)
CEO Representation. Subject to the last sentence of Section 3.1(f3.1(d), if the term of the Chief Executive Officer as a director on the Board is to expire in conjunction with any annual or special meeting of stockholders at which directors are to be elected, the Chief Executive Officer shall be included in the slate of nominees recommended by the Board for election.
Appears in 4 contracts
Sources: Stockholders Agreement (Evolent Health, Inc.), Stockholders Agreement (Evolent Health, Inc.), Shareholder Agreement (STORE CAPITAL Corp)
CEO Representation. Subject to the last sentence of Section 3.1(f3.1(e), if the term of the Chief Executive Officer as a director on the Board is to expire in conjunction with any annual or special meeting of stockholders shareholders at which directors are to be elected, the Chief Executive Officer shall be included in the slate of nominees recommended by the Board for election.
Appears in 3 contracts
Sources: Stockholders Agreement (Taylor Morrison Home Corp), Stockholders Agreement (Taylor Morrison Home Corp), Shareholder Agreements
CEO Representation. Subject to the last penultimate sentence of Section 3.1(f), if the term of the Chief Executive Officer as a director on the Board is to expire in conjunction with any annual or special meeting of stockholders shareholders at which directors are to be elected, the Chief Executive Officer shall be included in the slate of nominees recommended by the Board for election.
Appears in 2 contracts
Sources: Shareholder Agreement (Cushman & Wakefield PLC), Shareholder Agreement (Cushman & Wakefield PLC)
CEO Representation. Subject to the last sentence of Section 3.1(f3.1(g), if the term of the Chief Executive Officer CEO as a director on the Board is to expire in conjunction with any annual or special meeting of stockholders at which directors are to be elected, the Chief Executive Officer shall be included in the slate of nominees recommended by the Board for election.
Appears in 2 contracts
Sources: Stockholders Agreement (LifeStance Health Group, Inc.), Stockholders Agreement (LifeStance Health Group, Inc.)
CEO Representation. Subject to the second to last sentence of Section 3.1(f), if the term of the Chief Executive Officer as a director on the Board is to expire in conjunction with any annual or special meeting of stockholders at which directors are to be elected, the Chief Executive Officer shall be included in the slate of nominees recommended by the Board for election.
Appears in 1 contract
Sources: Shareholder Agreements (Ensemble Health Partners, Inc.)